New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
BASEL, Switzerland, Dec. 10 /PRNewswire/ -- New data being presented at
the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin
(trastuzumab), Avastin (bevacizumab) and oral Xeloda (capecitabine) continue
to offer new and better treatment options for breast cancer patients al...
Parasites That Live Inside Cells Use Loophole to Thwart Immune System
A study from St. Jude scientists shows how microbes can block nitric
oxide production - a chemical key to the immune system - and offers hints
for fighting bacteria
MEMPHIS, Tenn., Nov. 3 /PRNewswire-USNewswire/ -- St. Jude Children's
Research Hospital scientists have discovered a mechanism ...
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
BASEL, Switzerland, May 31 /PRNewswire/ --
- Thousands Of Patients Benefit Provided From Avastin-Based Therapy A wealth of new Avastin (bevacizumab) data will be presented at the
44th annual meeting of the American Society of Clinical Oncology (ASCO) in
Chicago confirming that Avastin-base...
MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
TURLOCK, Calif., Nov. 1 /PRNewswire/ -- In a move to improve
significantly the safety and well-being of Alzheimer's patients,
MedicAlert, a leader in emergency medical information service, has joined
the Alzheimer's Association a world leader in Alzheimer's research and
support, to offer Medic...
Framingham Study Shows Parents Who Live Long Pass On Lower Risk of
Cardiovascular Disease
BETHESDA, Md., March 13, 2007--New evidence suggests that if you
could choose your parents, you could reduce your risk of
cardiovascular disease. Researchers from the long-standing
Framingham Heart Study (FHS), a program of the National Heart,
Lung, and Blood Institute (NHLBI) of the National Insti...
Novavax Reports Positive Pre-Clinical Study Results from Live Virus
Challenge to Pandemic Flu Vaccine
Ferret Study to be Part of Data Package Required to Begin Clinical
Trials
ROCKVILLE, Md., May 03, 2007 /PRNewswire-FirstCall/ -- Novavax
Inc. said today that it has received positive study results from a
live virus challenge to ferrets inoculated with its pandemic
influenza vaccine, paving the way...
Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal
Challenge of Live Virus, Pre-Clinical Data Show
Study Presented at Second International Conference on Avian
Influenza at France's Pasteur Institute
PARIS, June 01, 2007 /PRNewswire-FirstCall/ -- Very low doses of
Novavax Inc.'s pandemic influenza vaccine provided protection
against a lethal challenge of
live H5N1 viruses, according to
pre-clini...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
... inflammatory disease collaboration with GSK.
Conference Call
At 08:30 a.m. Eastern Time today, August 6, Isis will conduct a
live webcast conference call to discuss this earnings release and related activities. Interested parties may listen to the call by dialing 866-788-0538 an...
SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
...ntation phase of the Oracle Life Science Application Suite (OLSAS) by going
live with Oracle Siebel Clinical Trial Management System and Oracle Adverse Even...ete operational functionality of the Oracle suite. SIRO, in April, had gone
live with the industry standard Oracle Clinical and Oracle RDC, integrated with ...
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
.... ET to discuss the preliminary results of the multiple ascending dose trial with PSI-7851. Investors may listen to the webcast of the conference call
live on the "Events & Presentations" section of Pharmasset's website, www.pharmasset.com . Alternatively, investors may listen to the call by dialin...
British Woman Celebrates a Year of Living Cancer-Free
...eatment has renewed her hope for the future. "I think to myself, 'What if I
live to my 70s or my 80s?'" she said. "I want to stay healthy and
live to be an old person."
Researchers at the Royal Free, led by principa...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...aw. She quickly sought treatment from area doctor, Chad Deal, M.D. and, thanks to her active lifestyle and the benefits of medications, she is able to
live a happy and functioning lifestyle.
"I really didn't think osteoporosis was a serious disease until I suffered a rib fracture while opening my c...
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
... homepage at http://www.rigel.com. To access the
live call, please dial 1-866-700-6293 (domestic) or 1...14211103. The conference call will also be webcast
live and can be accessed from Rigel's website at htt... website several minutes prior to the start of the
live webcast to ensure adequate time for any software d...
Injection Reverses Heart-Attack Damage
...nior investigator and a practicing pediatric cardiologist at Children's since 2007.
When the team injected NRG1 into the peritoneal cavity of
live mice after a heart attack, once daily for 12 weeks, heart regeneration was increased and pumping function (ejection fraction, assessed on echocardiogr...
Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
... at 4:30 p.m. ET. To access the call please dial 800-774-5358 U.S./Canada or 706-758-9475 International and enter passcode 20088902 or to listen to a
live webcast and view accompanying slides, go to "Calendar of Events" in the Idenix Investor Center at ww w .ideni x .com . A replay of the call wi...
Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
...o, California.
Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to
live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve th...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
...n be accessed at www.hgsi.com . Investors interested in listening to the
live webcast should log on before the conference call begins to download any sof...ng the quality of human life by enabling people to do more, feel better and
live longer. For more information, visit GlaxoSmithKline on the World Wide Web ...
Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
...rkets open. The announcement will be followed by a
live webcast and conference call at 8:00 a.m. Eastern t...of these clinical trials and answer questions. The
live call may be accessed by phone by calling 1-800-561...icipant code 14007929. The webcast can be accessed
live on the investor relations section of the Orexigen ...
GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas
...Rite Aid store-within-a-store locations) and franchise operations in 44 international markets. The company -- which is dedicated to helping consumers
live Well -- also offers products and product information online at www.gnc.com .
...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
...page at http://www.rigel.com . To access the
live call, please dial 866-543-6408 (domestic) or 617-2...8864759. The conference call will also be webcast
live and can be accessed from Rigel's website at htt... website several minutes prior to the start of the
live webcast to ensure adequate time for any software d...
Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
...ence Call and Webcast Information
To access the
live call, please dial 866-543-6408 (domestic) or 617-2...48864759. The conference call will also be webcast
live and can be accessed from Rigel's website at http:... website several minutes prior to the start of the
live webcast to ensure adequate time for any software d...
Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
...ch-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and
live longer. For further information please visit http://us.gsk.com/ .
Cervarix (R) is a registered trademark of the GlaxoSmithKline group of co...
Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research
...ly the researchers in the area of MS but also to the millions of people who
live with the disease on a daily basis," said Dr. Wolinsky. "We are extremely gr...at the tournament's Gala event on Tuesday, June 30. In total, the evening's
live auction generated $56,000 to further the MS-related goals of BAMS.
...
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
...an rFSH within a fixed budget, as it
offers considerable cost savings over rFSH, not only in terms of costs per
treatment cycle, but also in costs per
live births."
Health economic data
The new study determined the cost-effectiveness of different
gonadotropins in IVF cycles involving frozen ...
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
..., including serious infections without increased clinical benefit.
Patients treated with SIMPONI may receive concurrent vaccinations, except for
live vaccines. Non-serious allergic reactions associated with SIMPONI occurred in clinical trials, and included urticaria, bronchospasm, and hypersensitiv...
Inspiration for 'My Sister's Keeper' Speaks Out
...ernationally recognized expert in reproductive medicine whose Colorado Center for Reproductive Medicine (CCRM) was able to allow the Nash's embryos to
live longer outside the womb so they were more likely to survive, agrees with the Nashes that the book and movie have spurred an important discussion of th...
Alfacell Provides Shareholder Update
...unique opportunity to make a noticeable impact in the field of oncology giving those patients debilitated by these dreadful cancers the opportunity to
live meaningful lives while we continue to find better therapies and one day a permanent cure for cancer.
Sincerely,
Charles Muniz
President, C...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
... enables healthcare professionals and researchers to collect laboratory-quality physiological data from patients in the real-world settings where they
live and work. A fully integrated, non-invasive "smart garment," LifeShirt continuously monitors vital life-sign functions such as heart rate, respiratory ...
Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
... www.amylin.com .
Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to
live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve th...
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
... Afinitor is recommended when co-administered with a strong CYP3A4 inducer.
live vaccinations and close contact with those who have received
live vaccines should be avoided by patients taking Afinitor. Afinitor should not...
Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
...Diego, California.
Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to
live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve th...
Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
...rch-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and
live longer. For further information please visit www.gsk.com
Syncria(R) is the registered trademark to be used in the United States.
...
Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
...rch-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and
live longer. For more information please visit: www.us-gsk.com
Important safety information for Avandia (R) (rosiglitazone maleate)
...
WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... national surgical conferences.
Dr. Geffner plays an active role in the community and is involved with "Live from Kidney Transplant," a series of
live video telecasts of transplant surgery to high school students by Liberty Science Center. He is the Region 2 Representative on the Pancreas Transplant...
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
...TES procedure, transgastric cholecystectomy. Several devices specifically designed for natural orifice surgery were utilized in the study, including a
live video manipulation (LVM) system and magnetically anchoring and guidance system (MAGS). Study investigators specifically cited the retraction abilities...
Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
...Fee Act (PDUFA) date of July 31, 2009 for the Restanza NDA.
Conference Call Details
Advanced Life Sciences will host a conference call and
live webcast at 8:30 a.m. Eastern Time on Wednesday, June 3, 2009 to discuss the outcome of the AIDAC Review.
The conference call will be webcast simu...
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
...including vaccines or Kineret (anakinra), and if a woman is pregnant, plans to become pregnant or is nursing. Adults and children should not receive a
live vaccine while taking REMICADE.
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE.
Patients s...
Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
...ude, but are not limited to, diarrhea, anemia, abdominal pain, skin rash and weight loss. It is estimated that about 1% of people in the United States
live with celiac disease and the disease is greatly undiagnosed. The number of diagnosed patients is expected to increase significantly over the next sever...
Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
... to the liver, lung and bone[i]. Historically, metastatic melanoma patients
live less than two months before their disease progresses.
To view the Mult...cured with available treatments. Only a small proportion of people (<2%)
live more than two years once systemic metastases become evident[ii].
About...
FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)
...ch-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better, and
live longer. For company information, visit GlaxoSmithKline at www.gsk.com .
GSK Oncology is dedicated to producing innovations in cancer that w...